Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study.
Citation
Jain T, Estrada-Merly N, Queralt Salas M, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade Campos M, Elmariah H, Agrawal V, Aljurf M, Ulrike Bacher V, Badar T, Badawy S, Ballen K, Beitinjaneh A, Bhatt V, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald M, Hamad N, Hamilton B, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem M, Lad D, Liesveld J, Al Malki M, Malone AK, Murthy H, Ortí G, Patel S, Pawarode A, Perales M, van der Poel M, Ringden O, Rizzieri D, Rovo A, Savani B, Savoie M, Seo S, Solh M, Ustun C, Verdonck L, Wingard J, Wirk B, Bejanyan N, Jones R, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V.
Blood Advances. 2024, Aug 27: 8(16): 8(16):4281-4293. doi: 10.1182/bloodadvances.2024013451. Epub 2024, Jun 25. PMCID:PMC11372592.
PubMed
PMID: 38916866
Abstract